'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Learn how Excel functions can act as data using LAMBDA, LET, and BYROW, so you reuse logic and cut formula edits.

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Jujutsu Kaisen Modulo has upped the intensity once again and shocked the fans with the latest reveal of Yuka Okkotsu's ...

ProcessX posted BTS footage on YouTube showing how the Nissan Note with the e-Power hybrid system is made at the automaker’s ...

“Paddy Power has had a hugely positive impact on the World Darts Championship over the past two years,” said PDC Chief Executive Matt Porter once the news was announced. “Their creativity, investment ...

Ramanujan’s insights into pi are now guiding scientists toward a deeper understanding of how the universe works.

The Chicago Bears finally got a win over a team over .500 on Sunday. Barely, of course. The Bears have built an 8-3 record, which is fantastic, but they have done particularly well in two areas: ...